Skip to content
Stop using now Drug recall · FDA · Published November 8, 2023

Recall: Dr. Ergin's SugarMD Glucose Support Capsules Contain Hidden Drugs

SUGARMDS LLC recalls Dr. Ergin's SugarMD capsules because they are tainted with metformin and glyburide, drugs not listed on the label.

🇺🇸 FDA recall #D-0138-2024DrugSugarMD ›
Take action

Contact the company

Recalling firmSUGARMDS LLC11470 Schenk Dr · Maryland Heights, MO 63043-3417
✎ GovInfoNow plain-language explainer

SUGARMDS LLC is recalling Dr. Ergin's SugarMD Advanced Glucose Support Capsules because the product was marketed without an approved New Drug Application or Abbreviated New Drug Application. The recall was initiated after the product was found to be tainted with metformin and glyburide, prescription drugs that are not disclosed on the supplement label. This poses a significant health risk to consumers who may unknowingly ingest these medications. Read more at govinfonow.com/recall/33009-recall-dr-ergin-s-sugarmd-glucose-support-capsules-contain-hidden.

Source Summary by GovInfoNow · govinfonow.com/recall/33009-recall-dr-ergin-s-sugarmd-glucose-support-capsules-contain-hidden · Updated October 9, 2026 · FDA enforcement record: FDA #D-0138-2024

Cite this page

“Recall: Dr. Ergin's SugarMD Glucose Support Capsules Contain Hidden Drugs.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/33009-recall-dr-ergin-s-sugarmd-glucose-support-capsules-contain-hidden. Based on FDA recall #D-0138-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0138-2024%22&limit=1).

The Food and Drug Administration announced on Nov. 8, 2023, that SUGARMDS LLC is recalling Dr. Ergin's SugarMD ADVANCED GLUCOSE SUPPORT Capsules because they are tainted with the prescription drugs metformin and glyburide. The agency classified the Class I recall as voluntary.

How to tell if you have it

  • Brand: SugarMD
  • Product: Dr. Ergin's SugarMD, ADVANCED GLUCOSE SUPPORT Capsules
  • UPC: 1 95893 92767 8 (60 count)
  • UPC: 1 95893 54697 8 (120 count)
  • UPC: 1 95893 99957 6 (180 count)
  • Lot code: 22165-003
  • Expiration date: 09/30/2024

The hazard

The FDA said the dietary supplement was marketed without an approved New Drug Application or Abbreviated New Drug Application. The product was found to contain metformin and glyburide.

Context

GovInfoNow's records show other recent recalls of similar products include SUN PHARMACEUTICAL Xyvona 3mg Tablets Recall (2026-05-22) and Zydus Erythromycin Tablets Recall (2026-04-29).

How to tell if you have this one

Check your bottles for the brand name 'Dr. Ergin's SugarMD' and the description 'ADVANCED GLUCOSE SUPPORT Capsules'. Look for one of three UPC codes: 1 95893 92767 8 (60 count), 1 95893 54697 8 (120 count), or 1 95893 99957 6 (180 count). Verify the lot number is 22165-003 and the expiration date is 09/30/2024.

  • Brand
    SugarMD
  • Product
    Dr. Ergin's SugarMD, ADVANCED GLUCOSE SUPPORT Capsules, Dietary Supplement, helps support healthy glucose levels a) 60
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not consume any more of the recalled Dr. Ergin's SugarMD capsules immediately.

  2. Check your bottle details

    Verify that your product matches the brand, UPC codes, lot number 22165-003, and expiration date 09/30/2024.

  3. Contact the manufacturer

    Reach out to SUGARMDS LLC for further instructions on disposal or return, as specific remedy details are not provided in this record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide and online websites.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 35 days after the firm started it.

1. Firm started the recall: Nov 8, 202312. FDA classified it Class I: Dec 2, 202323. Published in FDA’s Enforcement Report: Dec 13, 202332023
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0138-2024 (November 8, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0138-2024 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA